深化AI技术在疾病诊断中的应用，凡知医学完成亿元级D+轮融资

Group 1 - Beijing Vanzhi Medical Technology Co., Ltd. has completed a billion-level D+ round financing, with participation from various investment institutions including Jianyin International and Jingshan Capital [1] - The financing will enhance the application of AI technology in rapid disease diagnosis, accelerate the R&D of AI-driven rapid testing instruments and multi-detection diagnostic reagents, and improve the smart diagnostic product matrix [1] - The company aims to significantly increase production capacity and deepen its global market presence, with overseas revenue expected to exceed one-third of total revenue, achieving industrialization and scaling [1] Group 2 - The founder and chairman, Dr. Song Keqing, expressed gratitude for the support from several prominent investment funds and outlined three strategic directions for the capital: deepening the integration of AI technology with rapid diagnostic products, accelerating the clinical transformation of new portable smart testing devices, and enhancing global expansion [2] - The company has maintained its mission of making precise diagnosis more convenient over the past nine years, with its intelligent portable devices and supporting reagents already in use in grassroots medical institutions across the country [2] - Vanzhi Medical is positioned at a critical turning point in medical AI, using this financing as an opportunity to upgrade AI and smart rapid diagnosis comprehensively, aiming to create a world-class intelligent diagnostic platform [2]